徳島大学 教育・研究者情報データベース(EDB)

1. 曽我部 正弘([徳島大学.キャンパスライフ健康支援センター])

   役割	任意
   貢献度	任意
   学籍番号	推奨

2. 岡久 稔也([徳島大学.大学院医歯薬学研究部.医学域.連携研究部門(医学域).寄附講座系(医学域).地域総合医療学]/[徳島大学.病院.診療科.内科.消化器内科])

   役割	任意
   貢献度	任意
   学籍番号	推奨

3. (英) Nakasono Masahiko

   役割	任意
   貢献度	任意
   学籍番号	推奨

4. 藤野 泰輝

   役割	任意
   貢献度	任意
   学籍番号	推奨

5. 三井 康裕([徳島大学.大学院医歯薬学研究部.医学域.先端医学教育研究プロジェクト]/[徳島大学.大学院医歯薬学研究部.医学域.医科学部門.内科系.消化器内科学])

   役割	任意
   貢献度	任意
   学籍番号	推奨

6. (英) Takaoka Yoshihumi

   役割	任意
   貢献度	任意
   学籍番号	推奨

7. 木村 哲夫

   役割	任意
   貢献度	任意
   学籍番号	推奨

8. 岡本 耕一([徳島大学.病院.診療科.内科.消化器内科])

   役割	任意
   貢献度	任意
   学籍番号	推奨

9. 六車 直樹

   役割	任意
   貢献度	任意
   学籍番号	推奨

10. 高山 哲治([徳島大学.大学院医歯薬学研究部.医学域.医科学部門.内科系.消化器内科学])

    役割	任意
    貢献度	任意
    学籍番号	推奨

(英) Investigation of Gastroduodenal Mucosal Injury in Japanese Asymptomatic Antiplatelet Drug Users

(英) Antiplatelet drugs are widely used for the prevention of cardiovascular disease and cerebral vascular disorders. Although there have been several studies on gastroduodenal mucosal injury with gastrointestinal (GI) symptoms such as GI bleeding, in antiplatelet drug users (including low-dose aspirin (LDA)), there have been few reports on the association between antiplatelet drug use and gastroduodenal mucosal injury in asymptomatic antiplatelet drug users. This study was a cross-sectional study elucidating the association between antiplatelet drug use and gastroduodenal mucosal injury in asymptomatic antiplatelet drug users.Subjects were 186 asymptomatic Japanese antiplatelet drug users who underwent a regular health checkup. Subjects were divided into those with and without gastroduodenal mucosal injury endoscopically, and the association between gastroduodenal mucosal injury and other data in asymptomatic antiplatelet drug users was investigated.The prevalence of males and drinkers were significantly higher in subjects with gastroduodenal mucosal injury than in those without. In addition, the prevalence of proton pump inhibitor (PPI) users was significantly lower in subjects with gastroduodenal mucosal injury than in subjects without gastroduodenal mucosal injury. Logistic regression analysis showed PPI (odds ratios: 0.116; 95% confidence intervals: 0.021-0.638; P < 0.05) was a significant predictor of a decreased prevalence of gastroduodenal mucosal injury and closed-type (C-type) atrophy (3.172; 1.322-7.609; P < 0.01) was a significant predictor of an increased prevalence of severe gastroduodenal mucosal injury in asymptomatic antiplatelet drug users.Gender and lifestyle, such as drinking, may have an impact on risk of gastroduodenal mucosal injury in asymptomatic subjects taking antiplatelet drugs. Although PPI is a significant predictor of a decreased prevalence of gastroduodenal mucosal injury, including in asymptomatic antiplatelet drug users, status of gastric atrophy should also be considered against severe gastroduodenal mucosal injury.

1. (英) Adult
2. (英) Aged
3. (英) Aged, 80 and over
4. (英) Endoscopy, Gastrointestinal
5. (英) Female
6. (英) Gastric Mucosa
7. (英) Humans
8. (英) Male
9. (英) Middle Aged
10. (英) Platelet Aggregation Inhibitors
11. (英) Retrospective Studies
12. (英) Stomach Diseases
13. (英) Young Adult

1. (英) Article.ELocationID: 10.1097/MD.0000000000001047

2. (英) Article.PublicationTypeList.PublicationType: Journal Article

3. (英) Article.PublicationTypeList.PublicationType: Observational Study

4. (英) OtherID: PMC4504548